Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis

Journal of Neuroimmunology

Volumn 276, Issue 1-2, 2014, Pages 64-70

  Guo, Yawei ^a   Chung, Sookja Kim ^a   Siu, Chung Wah ^a   Kwan, Shing Cheong ^a   Ho, Philip Wing Lok ^a   Yeung, Patrick Ka Kit ^a   Chan, Koon Ho ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endothelin 1; Experimental allergic encephalomyelitis; Multiple sclerosis; Proinflammatory cytokines; Th1 cells; Th17 cells

Indexed keywords

ENDOTHELIN 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE OVEREXPRESSION; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN BLOOD LEVEL; SPLEEN CELL; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; SPLEEN; TOXICITY;

ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; SPINAL CORD; SPLEEN;

EID: 84908509584     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.08.616     Document Type: Article

References (35)

1. Alvarez D., Braissouli P., Clancy R.M., Zavadil J., Reed J.H., Rosanna G.A., Hulushka M., Fox-Talbot K., Barrat F.J., Buyon J.P. A novel role of endothelin-1 in linking toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. J. Biol. Chem. 2011, 286(35):30444-30454.
2. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., Lee J., de Sauvage F.J., Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006, 7(9):929-936.
3. Chan K.H., Tsang K.L., Ho P.W.L., Tse C.T., Kwan J.S.C., Ho J.W.M., Chu A.C.Y., Chang R.S.K., Ho S.L. Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese. Clin. Neurol. Neurosurg. 2011, 113(8):617-622.
4. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372(9648):1502-1517.
5. Cunningham M.E., et al. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines. Crit. Care Med. 1997, 25(6):958-964.
6. D'Haeseleer M., et al. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(14):5654-5658.
7. Disanto G., Morahan J.M., Barnett M.H., Giovannoni G., Ramagopalan S.V. The evidence for a role of B cells in multiple sclerosis. Neurology 2012, 78(11):823-832.
8. Domingues H.S., Mues M., Lassmann H., et al. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS 2010, 5:e15531.
9. Du C., Liu C., Kang J., et al. MicroRNA miR 326 regulates Th-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
10. Filep J.G., et al. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br. J. Pharmacol. 1993, 109(3):880-886.
11. + regulatory B cells in experimental autoimmune encephalomyelitis. Neuroimmunomodulation 2013, 20:294-303.
12. Haufschild T., et al. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J. Neuroophthalmol. 2001, 21(1):37-38.
13. Hedegaard C.J., Krabauer M., Bendtzen K., et al. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 2008, 125:161-169.
14. Hung V.K., et al. Over-expression of endothelin-1 in astrocytes, but not endothelial cells, ameliorates inflammatory pain response after formalin injection. Life Sci. 2012, 91(13-14):618-622.
15. Javeshghani D., Barhoumi T., Idris-Khodja, Paradis P., Schiffrin E.L. Reduced macrophage-dependent inflammation improves endothelin-1 vascular injury. Hypertension 2013, 62:112-117.
16. Kebir H., Ifergan I., Alvarez J.I., et al. Preferential recruitment of interferon-gamma-expressing Th17 cells in multiple sclerosis. Ann. Neurol. 2009, 66:390-402.
17. Leung J.W., et al. Endothelial cell-specific over-expression of endothelin-1 leads to more severe cerebral damage following transient middle cerebral artery occlusion. J. Cardiovasc. Pharmacol. 2004, 44(Suppl. 1):S293-S300.
18. Leung J.W., Chung S.S., Chung S.K. Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res. 2009, 1266:121-129.
19. Lo A.C., et al. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J. Cereb. Blood Flow Metab. 2005, 25(8):998-1011.
20. Lucchinetti C.F., Brück W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Ann. Neurol. 2000, 47(6):707-717.
21. Matsushita T., Yanaba K., Bouaziz J.D., et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Investig. 2008, 12(118):3420-3430.
22. McKenzie A.L., et al. Immunolocalization of endothelin in the traumatized spinal cord: relationship to blood-spinal cord barrier breakdown. J. Neurotrauma 1995, 12(3):257-268.
23. Miller R.D., et al. NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow. J. Neurol. Sci. 1996, 136(1-2):37-40.
24. Miyasaka N., Hirata Y., Ando K., Sato K., Morita H., Shichiri M., Kanno K., Tomita K., Marumo F. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum. 1992, 35:397-400.
25. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343(13):938-952.
26. Pache M., et al. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur. Neurol. 2003, 49(3):164-168.
27. Rautureau Y., Schiffrin E.L. Endothelin in hypertension: an update. Curr. Opin. Nephrol. Hypertens. 2012, 21(2):128-136.
28. Reijerkerk A., Lakeman K.A.M., Drexhage J.A.R., can het Hof B., van Wijck Y., van der Pol S.M.A., Kooij G., Geerts D., de Vries H.E. Brain endothelial barrier passage by monocytes is controlled by the endothelin system. J. Neurochem. 2012, 121:730-737.
29. Shin T., et al. Intrathecal administration of endothelin-1 receptor antagonist ameliorates autoimmune encephalomyelitis in Lewis rats. Neuroreport 2001, 12(7):1465-1468.
30. Speciale L., et al. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 2000, 6(Suppl. 2):S62-S66.
31. Stromnes I.M., Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 2006, 1(4):1810-1819.
32. 't Hart B.A., Gran B., Weissert R. EAE: imperfect but useful models of multiple sclerosis. Trends Mol. Med. 2011, 17(3):119-125.
33. Yanagisawa M., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332(6163):411-415.
34. Yeung P.K., et al. Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage. BMC Neurosci. 2013, 14(1):131.
35. Zhang X., et al. Transgenic mice over-expressing endothelial endothelin-1 show cognitive deficit with blood-brain barrier breakdown after transient ischemia with long-term reperfusion. Neurobiol. Learn. Mem. 2013, 101:46-54.